RESEARCH

RESEARCH HIGHLIGHTS: LevaDopa

The symptoms of Parkinson’s disease are known to be related to the loss of dopamine-containing cells in the brain. LevaDopa, one of the first treatments for Parkinson’s Disease was aimed at trying to restore levels of dopamine in the brain.

LevaDopa is a chemical that can be converted to dopamine in the body. It was developed in the late 1960s and is given in pill-form, it is absorbed into the blood, travels through the blood to the brain where it is converted to dopamine.

The links below will help you learn more about LevaDopa, how it works, and its impact on our understanding of how Parkinson’s disease can be managed and treated.

PD - PathoPhys

The Pathophysiology of Parkinson’s Disease – The video will explain why the loss of dopamine has such a profound effect on the symptoms of Parkinson’s Disease

 

LDopa - past and future

LevaDopa Therapy for Parkinson’s Disease – Past and Future – A  review of the history of the use of LevaDopa and how it has shaped our understanding when designing new drugs to treat Parkinson’s disease.

 

Non-dopamine

Beyond Dopamine – Despite the traditional use of LevaDopa, and related drugs for Parkinson’s Disease, researchers have been exploring other ways in which to manage Parkinson’s Disease – this paper reviews these approaches.

FUTURE HIGHLIGHTS

  • Stem cells/transplantation therapies for Parkinson’s Disease
  • Food, nutrition and healthy living
  • Mitochondria – Cellular powerhouses and their role in Parkinson’s disease
  • Protein-misfolding – when naturally occurring proteins behave unnaturally
  • Diagnosis and early detection
  • Focus on caregivers.